Antara Capital’s Adverum Biotechnologies ADVM Stock Holding History

Antara Capital’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-107,500	Closed	-$1.02M	–	154
2022 Q3	$1.02M	Buy	+107,500	New	+$1.41M	0.03%	107

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

SGL

Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Antara Capital's ADVM Position: Q4 2022 in Review

Antara Capital sold out of Adverum Biotechnologies (ADVM) in Q4 2022, closing a stake of 107,500 shares — an estimated $1.02M sold.

Antara Capital first reported a position in ADVM in Q3 2022 and held it in 1 quarter. The position peaked at $1.02M in Q3 2022. 59 funds tracked by Wall St. Rank hold ADVM as of Q4 2022.

Antara Capital reported no remaining Adverum Biotechnologies position as of Q4 2022 after selling out during the quarter.
Antara Capital sold 107,500 Adverum Biotechnologies shares in Q4 2022, an estimated $1.02M.
Antara Capital first reported a position in Adverum Biotechnologies in Q3 2022 and held it in 1 quarter.
Antara Capital's Adverum Biotechnologies position peaked at $1.02M in Q3 2022.
59 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2022.

Based on Antara Capital's 13F filing for Q4 2022, filed 13 Feb 2023.